Related Experiment Videos

Cardiovascular Health Protects against Thyroid Dysfunction: Findings from the UK Biobank

Jilong Bai1,2, Rui Ren1,2, Panting Wei2

  • 1Department of Gerontology and Geriatrics, Shengjing Hospital of China Medical University, Shenyang, China.

Insights

Maintaining good cardiovascular health (CVH) significantly lowers the risk of developing thyroid dysfunction, including hyperthyroidism and hypothyroidism. This protective effect is amplified in individuals with positive mental health, highlighting the importance of holistic well-being.

Area of Science:

  • Cardiovascular Health
  • Thyroid Dysfunction
  • Mental Health

Background:

  • Limited research exists on the link between cardiovascular health (CVH) and thyroid dysfunction.
  • The influence of depression and anxiety on this relationship is not well understood.

Purpose of the Study:

  • To investigate the association between cardiovascular health and the risk of hyperthyroidism and hypothyroidism.
  • To explore the mediating role of inflammatory markers and the modifying effects of depression and anxiety.

Main Methods:

  • Longitudinal study of 360,332 UK Biobank participants without baseline thyroid disease.
  • Cox proportional hazards regression and weighted quantile sum regression were used to analyze associations and contributions of CVH components.
  • Multi-state models examined disease trajectories and the impact of mental health.

Main Results:

  • Higher CVH scores were linked to significantly lower risks of hyperthyroidism and hypothyroidism.
  • Obesity and tobacco use were major contributors to thyroid disease risk among CVH components.
  • Depression and anxiety modified the CVH-hypothyroidism association, with CVH showing protective effects across disease pathways.

Conclusions:

  • Favorable cardiovascular health is associated with reduced thyroid dysfunction risk.
  • Mental health status plays a crucial role in the protective effects of CVH against thyroid disease.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...